Server was unable to process request. ---> The data types ntext and varchar are incompatible in the equal to operator. Incorrect syntax near ')'. Incorrect syntax near the keyword 'declare'. Khandwala Securities Limited.
NIFTY
-3.60  -0.04%
 9630.00
S&P BSE SENSEX
7.10  0.02%
 31290.74
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 22-Jun-2017
NSE
10.8    1.65%
Rs. 665.95
 
Days Low
Rs. 658.75
Days High
Rs. 672

Open Rs. 658.8
 
52 week Low
Rs. 504
52 week High
Rs.895
 
 
Bid :                 665.70 (152)
Offer :        0.00 (0)
BSE
Rs.665.70
10.65    1.63%
on 22-Jun-2017
BSE
10.65    1.63%
Rs. 665.70
 
Days Low
Rs. 658
Days High
Rs. 672

Open Rs. 658.4
 
52 week Low
Rs. 503.05
52 week High
Rs.895
 
 
Bid :                 665.70 (152)
Offer :        0.00 (0)
NSE
Rs.665.95
10.8    1.65%
 
 
Last Price (Rs.)  665.70 Value  184190807.00
Net Change (Rs.)  10.65 Best Buy  665.70
Volume  276076 Best Sell  0.00
Prev.Close (Rs.)  655.05 Best Quantity  152
Open (Rs.)  658.80 Sell Quantity  0
High (Rs.)  672.00 52-Week High (Rs.)  895.00
Low (Rs.)  658.75 52-Week Low (Rs.)  504.00
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  390021.92
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Currents Investments0.20 196.40 0.30 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 538.70 1292506 86.99 0.00 0.65
Cadila Healthcare 526.05 538540 64.65 27.24 0.61
Piramal Enterprises 2893.75 499354 835.79 64.28 0.73
Lupin 1066.95 481943 327.21 16.66 0.70
Dr. Reddys Lab 2629.45 435968 699.67 33.12 0.76
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Mar 2017Dec 2016Sep 2016
Net Sales24200.9025213.7024101.60
Operating Profit6312.106634.806278.10
PBDT6221.506532.806158.80
Net Profit4554.604410.204192.40
More> 
 
Company News
6/15/2017 12:00:00 AM
Aurobindo Pharma receives USFDA approval for Sevelamer Carbonate oral ...
6/15/2017 12:00:00 AM
Aurobindo Pharma shines on receiving USFDA approval for Sevelamer Carb...
6/15/2017 12:00:00 AM
Aurobindo Pharma informs about press release
More>
 
Ratios
   Earnings Per Share (Rs)27.68 
   Book NAV/Share(Rs)116.38 
   PAT Margin (%)17.37 
   Asset Turnover(x)0.84 
   PER(x)26.92 
   Yield(%)0.34 
   EV/Core EBITDA(x)17.70 
   M Cap / Sales4.76 
   Net Sales Growth(%)13.23 
   PAT Growth(%)6.81 
   Total Debt/Equity(x)0.49 
   Current Ratio(x)1.54 
   Quick Ratio(x)1.00 
   Total Debt/Mcap(x)0.08 
More>